Yohei Doi Selected Research

Carbapenems (Carbapenem Antibiotics)

4/2022	Mechanisms of Reduced Susceptibility to Cefiderocol Among Isolates from the CREDIBLE-CR and APEKS-NP Clinical Trials.
1/2022	Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.
1/2022	Treatment of carbapenem-resistant Pseudomonas aeruginosa infections: a case for cefiderocol.
1/2022	Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial Resistance.
1/2021	Outcomes of Adjunctive Therapy with Intravenous Cefoperazone-Sulbactam for Ventilator-Associated Pneumonia Due to Carbapenem-Resistant Acinetobacter baumannii.
1/2021	Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.
1/2020	Unusual community-associated carbapenem-resistant Acinetobacter baumannii infection, Pennsylvania, USA.
1/2020	Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study.
11/2019	Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections.
10/2019	Clinical characteristics and outcomes of community and hospital-acquired Acinetobacter baumannii bacteremia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yohei Doi Research Topics

Disease

71	Infections 04/2022 - 04/2002
12	Urinary Tract Infections (Urinary Tract Infection) 03/2022 - 06/2014
11	Sepsis (Septicemia) 03/2022 - 02/2011
8	Bacteremia 03/2022 - 03/2002
7	COVID-19 08/2022 - 09/2020
7	Respiratory Sounds (Crackle) 01/2022 - 01/2017
5	Pneumonia (Pneumonitis) 08/2022 - 06/2014
4	Inflammation (Inflammations) 03/2022 - 01/2018
4	Chronic Renal Insufficiency 01/2022 - 09/2012
4	Neoplasms (Cancer) 03/2021 - 04/2012
3	Pseudomonas Infections 06/2022 - 01/2017
3	Communicable Diseases (Infectious Diseases) 03/2022 - 06/2014
3	Neutropenia 03/2022 - 03/2002
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 04/2012
3	Proteinuria 01/2021 - 12/2015
3	Gram-Negative Bacterial Infections 12/2020 - 01/2018
3	Intraabdominal Infections 09/2019 - 04/2012
2	Acidosis 05/2022 - 05/2022
2	Healthcare-Associated Pneumonia 04/2022 - 01/2021
2	Anemia 03/2022 - 10/2019
2	Water Intoxication 03/2022 - 01/2021
2	Hyperuricemia 02/2022 - 11/2020
2	Hypotension (Low Blood Pressure) 01/2022 - 01/2020
2	Endocarditis 04/2021 - 07/2019
2	Reinfection 01/2020 - 11/2018
2	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 12/2013
2	Respiratory Tract Infections (Respiratory Tract Infection) 07/2018 - 01/2017
2	Bacteriuria 12/2015 - 06/2014
1	Fever (Fevers) 08/2022
1	Ascites 06/2022
1	Body Weight (Weight, Body) 03/2022
1	Renal Insufficiency (Renal Failure) 03/2022
1	Metabolic Bone Diseases (Osteopenia) 01/2022
1	Osteoporosis 01/2022
1	Vitamin D Deficiency 01/2022
1	Hyperparathyroidism 01/2022
1	Cross Infection (Nosocomial Infection) 01/2022
1	Cat-Scratch Disease 01/2022
1	Trench Fever 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 12/2021
1	Hyponatremia 12/2021
1	Heart Failure 12/2021

Drug/Important Bio-Agent (IBA)

35	Carbapenems (Carbapenem Antibiotics)IBA 04/2022 - 01/2012
20	Anti-Bacterial Agents (Antibiotics)IBA 03/2022 - 01/2016
18	Colistin (Coly-Mycin)FDA Link 01/2022 - 08/2011
11	Pharmaceutical PreparationsIBA 06/2022 - 06/2011
8	carbapenemaseIBA 01/2020 - 08/2011
7	Fosfomycin FDA Link 11/2019 - 05/2014
6	AminoglycosidesIBA 04/2021 - 03/2007
6	Tigecycline (Tygacil)FDA Link 01/2020 - 09/2014
5	favipiravirIBA 08/2022 - 11/2020
4	CefiderocolIBA 04/2022 - 01/2019
4	CreatinineIBA 01/2021 - 12/2012
4	Polymyxins (Polymyxin)IBA 01/2021 - 01/2017
4	ceftazidime drug combination avibactamIBA 01/2018 - 12/2016
4	beta-Lactamases (beta-Lactamase)IBA 02/2011 - 03/2002
3	hydroxide ionIBA 03/2022 - 01/2020
3	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2021 - 04/2012
3	AlbuminsIBA 01/2021 - 12/2012
3	LactamsIBA 12/2020 - 02/2016
3	FluoroquinolonesIBA 12/2020 - 01/2017
3	CalciumIBA 10/2020 - 12/2015
3	Cefepime (Maxipime)FDA LinkGeneric 08/2019 - 12/2015
2	Cefmetazole (Cefmetazole Sodium)FDA Link 03/2022 - 11/2021
2	Vancomycin FDA LinkGeneric 03/2022 - 05/2013
2	Third Generation CephalosporinsIBA 01/2022 - 01/2019
2	VaccinesIBA 10/2021 - 01/2012
2	Immunoglobulin G (IgG)IBA 01/2021 - 09/2020
2	Vitamin D FDA LinkGeneric 10/2020 - 01/2020
2	AntibodiesIBA 09/2020 - 01/2020
2	meropenem and vaborbactamIBA 01/2020 - 01/2019
2	Complement System Proteins (Complement)IBA 01/2020 - 09/2012
2	Anti-Infective Agents (Microbicides)IBA 09/2019 - 05/2013
2	ProcalcitoninIBA 07/2018 - 01/2017
2	sultamicillin (ampicillin-sulbactam)FDA LinkGeneric 05/2015 - 02/2011
2	beta-LactamsIBA 03/2007 - 03/2002
1	DiureticsIBA 06/2022
1	Bicarbonates (Hydrogen Carbonate)IBA 05/2022
1	PolymersIBA 05/2022
1	veverimerIBA 05/2022
1	flomoxefIBA 03/2022
1	IronIBA 03/2022
1	Antiviral Agents (Antivirals)IBA 02/2022
1	Uric Acid (Urate)IBA 02/2022
1	25-hydroxyvitamin DIBA 01/2022
1	GlucocorticoidsIBA 01/2022
1	Mineralocorticoid Receptor AntagonistsIBA 01/2022
1	Virulence Factors (Pathogenicity Factors)IBA 01/2022
1	Methylprednisolone FDA LinkGeneric 12/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2021
1	Tolvaptan FDA Link 12/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021
1	Pancreatic Elastase (Elastase)IBA 11/2021

Therapy/Procedure

33	Therapeutics 08/2022 - 02/2011
5	Renal Dialysis (Hemodialysis) 01/2022 - 01/2019
3	Urinary Catheters 03/2022 - 04/2012
2	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2021 - 01/2017
2	Artificial Respiration (Mechanical Ventilation) 01/2020 - 12/2013
1	Hemodilution 03/2022
1	Kidney Transplantation 01/2022